No consumer responses were received during the public consultation period.
Approach to assessment
To determine whether there is sufficient evidence, in relation to safety, effectiveness and cost-effectiveness, to have NAAT listed on the MBS for the diagnosis of MTB in patients with the signs and symptoms of active TB, and NTM in patients suspected of having an NTM infection.
A systematic review (SR) of published medical literature was undertaken. Searches to identify relevant studies and reviews for the period between 1990 and June 2014 were conducted for the Cochrane Library, Current Contents, Embase, PubMed, Web of Science, Cinahl, Econlit and Scopus databases, as well as Australian and international health technology assessment (HTA) websites.
Dostları ilə paylaş: |
